Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy.
Ontology highlight
ABSTRACT: At the annual prestigious International Symposium of the Fritz-Bender Foundation, Munich, 18-20 May, 2016, researchers, clinicians, and students discussed the state of the art and future perspectives of genomic medicine in cancer. Genomic medicine (also known as precision medicine/oncology) should help clinicians to provide a more precise diagnosis and therapy in oncology for individual patients. The meeting focused on next-generation sequencing methods, analytical computational analysis of big data, and data mining on the way to translational and evidence-based medicine. The meeting covered the social and ethical impact of genomic medicine as well as news and views on antibody targeting of intracellular proteins, on the architecture of intracellular proteins and their impact on carcinogen
SUBMITTER: Zanker KS
PROVIDER: S-EPMC6945940 | biostudies-literature | 2016 Sep-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA